Quantitative profiling of colorectal cancer-associated bacteria reveals associations between Fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Viljoen, Katie S ^a   Dakshinamurthy, Amirtha ^a   Goldberg, Paul ^b   Blackburn, Jonathan M ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMPLICON; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM DETECTION; BACTEROIDES FRAGILIS; CANCER PATIENT; CANCER STAGING; CLINICAL FEATURE; COHORT ANALYSIS; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTEROCOCCUS FAECALIS; ENTEROPATHOGENIC ESCHERICHIA COLI; ENTEROTOXIGENIC BACTEROIDES FRAGILIS; FEMALE; FUSOBACTERIUM; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; NONHUMAN; OPERON; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; STREPTOCOCCUS GALLOLYTICUS; ADENOCARCINOMA; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL LOAD; CASE CONTROL STUDY; COLON; COLORECTAL TUMOR; GENETICS; MICROBIOLOGY; PATHOLOGY; RECTUM;

BACTERIA (MICROORGANISMS); BACTEROIDES FRAGILIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FUSOBACTERIUM; STREPTOCOCCUS GALLOLYTICUS;

ADENOCARCINOMA; ADULT; BACTERIAL INFECTIONS; BACTERIAL LOAD; BACTEROIDES FRAGILIS; CASE-CONTROL STUDIES; COLON; COLORECTAL NEOPLASMS; ENTEROPATHOGENIC ESCHERICHIA COLI; FEMALE; FUSOBACTERIUM; GENES, BACTERIAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RECTUM;

EID: 84928905886     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119462     Document Type: Article

References (72)

1. Schiff M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370:890-907. PMID: 17826171
2. Manuel A, Machado D, Figueiredo C, Seruca R, Juel L. Helicobacter pylori infection generates genetic instability in gastric cells. Biochim Biophys Acta. Elsevier B. V.; 2010; doi: 10.1016/j.bbcan. 2010.01.007
3. Vogelmann R, Amieva MR. The role of bacterial pathogens in cancer. Curr Opin Microbiol. 2007;10:76-81. doi: 10.1016/j.mib.2006.12.004 PMID: 17208515
4. McCoy WC, JMM 3rd. Enterococcal endocarditis associated with carcinoma of the sigmoid; report of a case. Journal Med Assoc State Alabama. 1951;21.
5. Warren L, Freeman JD, Dreolini L, Castellarin M, Krzywinski M, Strauss J, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22:299-306. doi: 10. 1101/gr.126516.111 PMID: 22009989
6. McCoy AN, Araújo-Pérez F, Azcárate-Peril A, Yeh JJ, Sandler RS, Keku TO. Fusobacterium is associated with colorectal adenomas. PLoS One. 2013;8:e53653. doi: 10.1371/journal.pone.0053653 PMID: 23335968
7. Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012;292-298. doi: 10.1101/gr.126573.111 PMID: 23132912
8. Gupta A, Madani R, Mukhtar H. Streptococcus bovis endocarditis, a silent sign for colonic tumour. Color Dis. 2010;12:164-171. doi: 10.1111/j.1463-1318.2009.01814.x PMID: 19226366
9. Abdulamir AS, Hafidh RR, Bakar FA. Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential. Mol Cancer. 2010;9:1-18. doi: 10.1186/1476-4598-9-1 PMID: 20051109
10. Boleij A, Van Gelder MMHJ, Swinkels DW, Tjalsma H. Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis. 2011;53:870-8. doi: 10.1093/cid/cir609 PMID: 21960713
11. Balamurugan R, Rajendiran E, George S, Samuel GV, Ramakrishna BS. Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J Gastroenterol Hepatol. 2008;23:1298-303. doi: 10. 1111/j.1440-1746.2008.05490.x PMID: 18624900
12. Toprak NU, Yagci A, Gulluoglu BM, Akin ML, Demirkalem P, Celenk T, et al. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect. 2006;12:782-6. doi: 10.1111/j.1469-0691.2006.01494.x PMID: 16842574
13. Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, Weber J, et al. Association Between Intraepithelial Escerichia coli and Colorectal Cancer. Gastroenterology. 1998;115:281-286. PMID: 9679033
14. Wu S, Morin PJ, Maouyo D, Sears CL. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology. 2003;124:392-400. doi: 10.1053/gast.2003.50047 PMID: 12557145
15. Umar S, Wang Y, Morris AP, Sellin JH. Dual alterations in casein kinase I-E and GSK-3β modulate β-catenin stability in hyperproliferating colonic epithelia. Am J Physiol Gastrointest Liver Physiol. 2007;292:599-607. doi: 10.1152/ajpgi.00343.2006
16. Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe. Elsevier Inc.; 2013;14:195-206. doi: 10.1016/j.chom.2013.07.012 PMID: 23954158
17. Balish E, Warner T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol. American Society for Investigative Pathology; 2002;160:2253-7. doi: 10.1016/S0002-9440 (10) 61172-8 PMID: 12057927
18. Kim SC, Tonkonogy SL, Albright CA, Tsang J, Balish EJ, Braun J, et al. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology. 2005;128:891-906. doi: 10.1053/j.gastro.2005.02.009 PMID: 15825073
19. Ellmerich S, Schöller M, Duranton B, Gossé F, Galluser M, Klein JP, et al. Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis. 2000;21:753-6. PMID: 10753212
20. Biarc J, Nguyen IS, Pini A, Gossé F, Richert S, Thiersé D, et al. Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis). Carcinogenesis. 2004;25:1477-84. doi: 10.1093/carcin/bgh091 PMID: 14742316
21. David O, Maddocks K, Scanlon KM, Donnenberg MS. An Escherichia coli Effector Protein Promotes Host Mutation via Depletion of DNA Mismatch Repair Proteins. MBio. 2013;4. doi: 10.1128/mBio. 00152-13
22. Prorok-Hamon M, Friswell MK, Alswied A, Roberts CL, Song F, Flanagan PK, et al. Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer. Gut. 2014;63:761-70. doi: 10.1136/gutjnl-2013-304739 PMID: 23846483
23. Buc E, Dubois D, Sauvanet P, Raisch J, Delmas J. High Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon Cancer. PLoS One. 2013;8. doi: 10.1371/journal.pone. 0056964
24. Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. PNAS. 2010;107. doi: 10.1073/pnas.1001261107
25. Maddocks ODK, Short AJ, Donnenberg MS, Bader S, Harrison DJ. Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans. PLoS One. 2009;4:e5517. doi: 10.1371/journal.pone.0005517 PMID: 19436735
26. Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology. 2004;127:80-93. doi: 10. 1053/j.gastro.2004.03.054 PMID: 15236175
27. Kotlowski R, Bernstein CN, Sepehri S, Krause DO. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut. 2007;56:669-75. doi: 10.1136/gut. 2006.099796 PMID: 17028128
28. Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan T-J, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012;338:120-3. doi: 10.1126/science.1224820 PMID: 22903521
29. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. Elsevier Inc.; 2013;14:207-15. doi: 10.1016/j.chom.2013.07.007 PMID: 23954159
30. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. Nature Publishing Group; 2009;15:1016-22. doi: 10.1038/nm.2015 PMID: 19701202
31. Corredoira-Sánchez J, García-Garrote F, Rabuñal R, López-Roses L, García-País MJ, Castro E, et al. Association between bacteremia due to Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis I) and colorectal neoplasia: a case-control study. Clin Infect Dis. 2012;55:491-6. doi: 10.1093/cid/cis434 PMID: 22563018
32. Huycke MM, Abrams V, Moore DR. Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis. 2002;23:529-536. PMID: 11895869
33. Wang X, Allen TD, May RJ, Lightfoot S, Houchen CW, Huycke MM. Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect. Cancer Res. 2008;68:9909-17. doi: 10.1158/0008-5472. CAN-08-1551 PMID: 19047172
34. Loukola A, Eklin K, Laiho P, Salovaara R, Kristo P, Järvinen H, et al. Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res. 2001;61:4545-9. PMID: 11389088
35. Imai K, Yamamoto H. Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis. 2008;29:673-80. doi: 10.1093/carcin/bgm228 PMID: 17942460
36. Lindor BNM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ, et al. Immunohistochemistry Versus Microsatellite Instability Testing in Phenotyping Colorectal Tumors. 2002;20:1043-1048. PMID: 11844828
37. Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics. 2012;13:134. doi: 10.1186/1471-2105-13-134 PMID: 22708584
38. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS. "Touchdown" PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res. 1991;19:4008. PMID: 1861999
39. Dolezel J, Bartos J, Voglmayr H, Greilhuber J. Nuclear DNA content and genome size of trout and human. Cytometry A. 2003;51:127-8. doi: 10.1002/cyto.a.10013 PMID: 12541287
40. Sedgley CM, Nagel AC, Shelburne CE, Clewell DB, Appelbe O, Molander A. Quantitative real-time PCR detection of oral Enterococcus faecalis in humans. Arch Oral Biol. 2005;50:575-83. doi: 10. 1016/j.archoralbio.2004.10.017 PMID: 15848151
41. Vìtrovski T, Baldrian P. The variability of the 16S rRNA gene in bacterial genomes and its consequences for bacterial community analyses. PLoS One. 2013;8:e57923. doi: 10.1371/journal.pone. 0057923 PMID: 23460914
42. Miquel S, Peyretaillade E, Claret L, De Vallée A, Dossat C, Vacherie B, et al. Complete genome sequence of Crohn's disease-associated adherent-invasive E. coli strain LF82. PLoS One. 2010;5. doi: 10.1371/journal.pone.0012714
43. Rusniok C, Couvé E, Da Cunha V, El Gana R, Zidane N, Bouchier C, et al. Genome sequence of Streptococcus gallolyticus: insights into its adaptation to the bovine rumen and its ability to cause endocarditis. J Bacteriol. 2010;192:2266-76. doi: 10.1128/JB.01659-09 PMID: 20139183
44. Van Beers EH, Joosse SA, Ligtenberg MJ, Fles R, Hogervorst FBL, Verhoef S, et al. A multiplex PCR predictor for aCGH success of FFPE samples. Br J Cancer. 2006;94:333-7. doi: 10.1038/sj.bjc. 6602889 PMID: 16333309
45. Tahara T, Yamamoto E, Suzuki H, Maruyama R, Chung W, Garriga J, et al. Fusobacterium in colonic flora and molecular features of colorectal carcinoma. Cancer Res. 2014;74:1311-8. doi: 10.1158/0008-5472. CAN-13-1865 PMID: 24385213
46. Zhang G, Svenungsson B, Karnell A, Weibtraub A. Prevalence of Enterotoxigenic Bacteroides fragilis in Adult Patients with Diarrhea and Healthy Controls. Clin Infect Dis. 1999;29:590-594. PMID: 10530453
47. Buc E, Dubois D, Sauvanet P, Raisch J, Delmas J, Darfeuille-Michaud A, et al. High prevalence of mucosaassociated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS One. 2013;8:e56964. doi: 10.1371/journal.pone.0056964 PMID: 23457644
48. Xue-Han Z, Qing Y, Ya-Dong L, Bin L, Renata I, Kong-Wang H. Development of a LAMP assay for rapid detection of different intimin variants of attaching and effacing microbial pathogens. J Med Microbiol. 2013;62:1665-1672. doi: 10.1099/jmm.0.054551-0 PMID: 23893919
49. Phillips AD, Navabpour S, Hicks S, Dougan G, Wallis T, Frankel G, et al. Enterohaemorrhagic Escherichia coli O157:H7 target Peyer's patches in humans and cause attaching/effacing lesions in both human and bovine intestine. 2000;377-381. PMID: 10940275
50. Fitzhenry R J, Pickard D J, Hartland E L, Reece S, Dougan G, Phillips GF A D. Intimin type influences the site of human intestinal mucosal colonisation by enterohaemorrhagic Escherichia coli O157:H7. Gut. 2002;50:180-185. PMID: 11788556
51. Mundy R, Schüller S, Girard F, Fairbrother JM, Phillips AD, Frankel G. Functional studies of intimin in vivo and ex vivo: implications for host specificity and tissue tropism. Microbiology. 2007;153:959-67. doi: 10.1099/mic.0.2006/003467-0 PMID: 17379706
52. Bonnet M, Buc E, Sauvanet P, Darcha C, Dubois D, Pereira B, et al. Colonization of the human gut by E. coli and colorectal cancer risk. Clin Cancer Res. 2014;20:859-67. doi: 10.1158/1078-0432.CCR-13-1343 PMID: 24334760
53. Cummins J, Tangney M. Bacteria and tumours: causative agents or opportunistic inhabitants? Infect Agent Cancer. 2013;8:11. doi: 10.1186/1750-9378-8-11 PMID: 23537317
54. Hartnett L, Egan LJ. Inflammation, DNA methylation and colitis-associated cancer. Carcinogenesis. 2012;33:723-31. doi: 10.1093/carcin/bgs006 PMID: 22235026
55. Strauss J, Kaplan GG, Beck PL, Rioux K, Panaccione R, Devinney R, et al. Invasive potential of gut mucosaderived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis. 2011;17:1971-8. doi: 10.1002/ibd.21606 PMID: 21830275
56. Cronjé L, Paterson A, Becker PJ. Colorectal cancer in South Africa: a heritable cause suspected in many young black patients. S Afr Med J. 2009;99:103-6. PMID: 19418671
57. Bremner C, Ackerman V. Polyps and carcinoma of the large bowel in the South African Bantu. Cancer. 1970;26:991-999. PMID: 5476799
58. Degiannis E, Sliwa K, Levy R, Hale M, Saadia R. Clinicopathological trends in colorectal carcinoma in a Black South African population. Trop Gastroenterol. 1995;16:55-61. PMID: 8854959
59. Cronjé L, Becker PJ, Paterson AC, Ramsay M. Hereditary non-polyposis colorectal cancer is predicted to contribute towards colorectal cancer in young South African blacks. S Afr J Sci. 2009;105. doi: 10. 1590/S0038-23532009000100023
60. Kaz A, Kim YH, Dzieciatkowski S, Lynch H, Watson P, Kay Washington M, et al. Evidence for the role of aberrant DNA methylation in the pathogenesis of Lynch syndrome adenomas. Int J Cancer. 2007;120:1922-9. doi: 10.1002/ijc.22544 PMID: 17278092
61. Speake D, O'Sullivan J, Evans DG, Lalloo F, Hill J, McMahon RFT. Hyperplastic polyps are innocuous lesions in hereditary nonpolyposis colorectal cancers. Int J Surg Oncol. 2011;2011:653163. doi: 10. 1155/2011/653163 PMID: 22312515
62. Parsons MT, Buchanan DD, Thompson B, Young JP, Spurdle AB. Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification. J Med Genet. 2012;49:151-7. doi: 10.1136/jmedgenet-2011-100714 PMID: 22368298
63. Bettstetter M, Dechant S, Ruemmele P, Grabowski M, Keller G, Holinski-Feder E, et al. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Clin Cancer Res. 2007;13:3221-8. doi: 10.1158/1078-0432. CCR-06-3064 PMID: 17545526
64. Ollikainen M, Hannelius U, Lindgren CM, Abdel-Rahman WM, Kere J, Peltomäki P. Mechanisms of inactivation of MLH1 in hereditary nonpolyposis colorectal carcinoma: a novel approach. Oncogene. 2007;26:4541-9. doi: 10.1038/sj.onc.1210236 PMID: 17260015
65. Zhang J, Lindroos A, Ollila S, Russell A, Marra G, Mueller H, et al. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers. Cancer Res. 2006;66:659-64. doi: 10.1158/0008-5472. CAN-05-4043 PMID: 16423994
66. Wheeler JM, Loukola A, Aaltonen LA, Mortensen NJ, Bodmer WF. The role of hypermethylation of the hMLH1 promoter region in HNPCC versus MSI+ sporadic colorectal cancers. J Med Genet. 2000;37:588-92. PMID: 10922385
67. Jass JR. HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences. Am J Pathol. 2004;3:93-100.
68. Patil DT, Shadrach BL, Rybicki LA, Leach BH, Pai RK. Proximal colon cancers and the serrated pathway: a systematic analysis of precursor histology and BRAF mutation status. Mod Pathol. Nature Publishing Group; 2012;25:1423-31. doi: 10.1038/modpathol.2012.98 PMID: 22684223
69. Gebert J, Kloor M, Lee J, Lohr M, André S, Wagner R, et al. Colonic carcinogenesis along different genetic routes: glycophenotyping of tumor cases separated by microsatellite instability/stability. Histochem Cell Biol. 2012;138:339-50. doi: 10.1007/s00418-012-0957-9 PMID: 22565205
70. Campbell BJ, Yu LG, Rhodes JM. Altered glycosylation in inflammatory bowel disease: a possible role in cancer development. Glycoconj J. 2003;18:851-8.
71. Kostic AD, Chun E, Meyerson M, Garrett WS. Microbes and inflammation in colorectal cancer. Cancer Immunol Res. 2013;1:150-7. doi: 10.1158/2326-6066. CIR-13-0101 PMID: 24777677
72. Dutilh BE, Backus L, Van Hijum SAFT, Tjalsma H. Screening metatranscriptomes for toxin genes as functional drivers of human colorectal cancer. Best Pract Res Clin Gastroenterol. 2013;27:85-99. doi: 10.1016/j.bpg.2013.03.008 PMID: 23768555